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Abstract 
Background: Coronavirus disease 2019 (COVID-19), caused by the severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a disorder with 
human-to-human rapid transmission. With several vaccines introduced, we 
need to find out the effectiveness of such medications in a short-period 
therapeutic procedure. The NTPase/helicase plays a key role in the replication 
of the viral RNA.  
Materials and Methods: We estimated the binding affinity of several natural 
polyphenolics, commonly found in fruits and vegetables, with the catalytic site 
of SARS-CoV-2 helicase by molecular docking analysis using the AutoDock 
tool. The stability of connections between top-ranked components inside the 
catalytic site of the helicase was evaluated by molecular dynamics (MD) 
simulations. The most active residues within the catalytic site of the helicase 
were ranked based on their degree in a phenolic-residue interaction (PRI) 
network.  
Results: Amentoflavone, theaflavin 3'-gallate, and procyanidin were 
estimated to be the most potential effective SARS-CoV-2 helicase inhibitors 
with the salient inhibition constant value (Ki) at the picomolar scale. The 
docked pose of these compounds was also found to be stable after MD 
simulations. The binding energy of these compounds with the helicase 
catalytic site was estimated between −13.90 and −12.77 kcal/mol. Asp534 
and Leu412 demonstrated more degrees in the PRI network compared to the 
other residues.  
Conclusion: The present study predicts that amentoflavone, theaflavin 3'-
gallate, and procyanidin might be helpful for the treatment of COVID-19.  
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Introduction 
Severe Acute Respiratory Syndrome Coronavirus 2 
(SARS-CoV-2), a new form of SARS-CoV, first 
emerged from Wuhan, China, in December 2019. The 
corresponding pandemic caused by the SARS-CoV-2 
is coronavirus disease 2019 (Covid-19) by the World 
Health Organization (WHO), which has a fast and wide 
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transmission. The Covid-19 may lead to severe acute 
pneumonia in a considerable number of patients, 
causing organ failure and death (1-3). Although 
scientists have discovered and introduced several 
vaccines to diminish the spread of the infection, several 
complications have remained. For example, mRNA-
based vaccines must be stored at −70 degrees Celsius, 
which may not be possible in common medical centers. 
Moreover, the production and delivery of vaccines for 
billions of people around the world have logistical 
obstacles. Therefore, it is still necessary to discover 
effective and safe drugs to combat Covid-19 in a short-
time therapeutic strategy (4, 5). 
A major conserved protein in coronaviruses is 
NTPase/helicase (NSP13), with a central role in the 
virus's life cycle. It is responsible for unwinding the 
double-stranded RNA of the virus by consuming 
energy from nucleoside triphosphates (6). Therefore, 
NTPase/helicase has become an attractive target for 
therapeutic aims in patients affected by coronaviruses 
(7-12). 
In addition to synthesized antiviral drugs (e.g., 
ribavirin, favipiravir, lopinavir, and ritonavir), which 
are frequently used against the Covid-19 pandemic 
(13-15), natural plant-based compounds may serve as 
an alternative for therapeutic aims in patients affected 
by SARS-CoV-2 (16-18). Polyphenols (also known as 
phenolics), the secondary metabolites produced by 
plants, help elevate the survival of herbs by interacting 
with unusual environmental conditions such as hazard 
radiations and pathogens. They are also responsible for 
many herbal colors (e.g., apples, barriers, and onions). 
Moreover, phenolic compounds are one of the most 
abundant molecules found in nutraceutical foods 
(functional foods), representing several medical and 
health advantages for treating and preventing 
disorders. Fruits, vegetables, cereals, olive, legumes, 
chocolate, and famous beverages such as tea and coffee 
are the main sources of these natural components. 
Structurally, they consist of at least one aromatic ring 
with one or more OH groups (19-24). Phenolics are 
classified into flavonoids, tannins, phenolic acids, 
lignans, and stilbenes (25). Flavonoids are the most 
generous phenolic compounds in daily diet with 
various pharmacological features, including 
antioxidant, anti-inflammatory, antibacterial, and 
antiviral effects (26). The antiviral activity of several 
flavonoids on DNA and RNA viruses has been 
confirmed by previous studies (27). For example, it has 
been demonstrated that apigenin contributes to 
inhibiting the protein synthesis of picornavirus (RNA 
virus), leading to an inactive form of the virus (28). 
Furthermore, epigallocatechin-3-gallate inhibits 
DNA replication in herpes simplex, hepatitis B virus, 
and adenovirus (29). Besides, amentoflavone has 
illustrated antiviral activity against several viruses (30-
32). Therefore, in the present study, it was suggested 
that polyphenolics contribute to disrupting the normal 
activity of NTPase/helicase in SARS-CoV-2 via 
attaching to the catalytic domain of the enzyme. 
The present study aimed to perform a drug 
discovery approach using a molecular docking study to 
analyze the binding affinity of a total of 52 phenolics 
(mostly flavonoids) with the catalytic domain of 
SARS-CoV-2 NTPase/helicase to examine our 
hypothesis. Identifying compounds with a high affinity 
of binding to the SARS-CoV-2 catalytic domain may 
lead to the identification of new drug candidates for the 
therapeutic aims of Covid-19; Executing molecular 
dynamics (MD) simulation to examine the resistance 
of interactions between salient predicted inhibitors and 
the residues within the SARS-CoV-2 helicase catalytic 
domain to investigate the stability of docked pose of 
top inhibitors; Finding the amino acids most 
efficacious in ligand binding. This was carried out by 
calculating the degree of each amino acid in the 
phenolics-residue interaction (PRI) network, which 
represents the number of interactions between residues 
and top-ranked inhibitors. 
 
Methods 
The Ethics committee approved the present study of 
Hamadan university of medical sciences, Hamadan, 
Iran (ethics no. IR.UMSHA.REC.1399.1025). No 
human/animal was used in this study. The datasets 
used and/or analyzed during the current study are 
available from the corresponding author on reasonable 
request. 
 
Structure preparation: The crystal structure of 
SARS-CoV-2 helicase was achieved from the 
Structural Bioinformatics Protein Data Bank 
(https://www.rcsb.org) as a Protein Data Bank file 
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(PDB code: 5RLJ) at 1.88 Å X-ray resolution. The 
5RLJ file included two chains representing the helicase 
enzyme, named A and B. Chain B was chosen for 
molecular docking operations, including 592 residues. 
Discovery Studio Client version 16.1.0.15350 
(https://discover.3ds.com/discovery-studio-visualizer-
download) was utilized to minimize the protein's 
energy (EM). The inhibitor of the helicase in Newman 
et al.’s study (https://www.rcsb.org/structure/5RLJ), 
(2S)-2-phenylpropane-1-sulfonamide (PDB code: 
VW4) was eliminated from the crystal structure before 
EM. The binding affinity of 52 natural phenolic 
compounds to the catalytic domain of SARS-CoV-2 
helicase was examined. Moreover, vapreotide 
(PubChem code: 6918026), atazanavir (PubChem 
code: 148192), ivermectin (PubChem code: 6321424), 
and scutellarein (PubChem code: 5281697) were 
considered as control inhibitors of the SARS-CoV-2 
helicase. Borgio et al. (11) reported that vapreotide and 
atazanavir (two of the clinically approved drugs 
against the human immunodeficiency virus [HIV] 
infection) revealed a considerable binding affinity to 
the SARS-CoV-2 helicase. This was carried out by a 
molecular docking study using the MOE software. 
Besides, Yu et al. (12) demonstrated that scutellarein 
acts as an inhibitor of the SARS-CoV helicase by 
affecting the ATPase activity of the enzyme in vitro. 
Moreover, Khater et al. (33) noted that ivermectin 
revealed an anti-SARS-CoV-2 helicase activity in 
vitro. Ivermectin has antiparasitic activity and has been 
approved by the food and drug administration (FDA). 
The PubChem database 
(https://pubchem.ncbi.nlm.nih.gov) and the cactus web 
server (http://cactus.nci.nih.gov/chemical/structure) 
was utilized to download the structure-data file (SDF) 
of the compounds and to translate the SDF formats to 
the PDB files, respectively. The EM for all ligands was 
performed using the HyperChem software version 
8.0.10. 
 
Molecular docking and dynamics simulation: In the 
present study, we used a windows-based PC to achieve 
molecular docking and MD simulations. The installed 
memory, processor, and system type associated with 
our PC were 32 Gigabytes, Intel Core i7, and 64-bit, 
respectively. AutoDock software version 4.0 
(http://autodock.scripps.edu) and the Discovery Studio 
Client version 16.1.0.15350 were utilized to study 
molecular docking and MD simulations. The 
Lamarckian Genetic Algorithm is the method applied 
by the AutoDock to locate the compound inside the 
protonated protein (34-36). After the connection 
between ligand, the Gibbs free energy of binding (∆G 
binding) is estimated by the coming formula (37, 38): 
∆G binding = Intermolecular Energy + Total 
Internal Energy + Torsional Free Energy - Unbound 
System's Energy 
The catalytic domain of SARS-CoV-2 helicase 
was considered as the pocket for docking analysis with 
phenolic compounds. The grid box options were set to 
spacing, 0.375 Å; X-dimension, 126; Y-dimension, 
124; Z-dimension, 98. The Discovery Studio Client 
version 16.1.0.15350 was employed to detect the main 
residues within the helicase catalytic domain.  
This was carried out by analyzing the 2-
dimensional (2D) view of interactions between the 
amino acids and small molecules inside the SARS-
CoV-2 NTPase/helicase in several studies performed 
by Newman et al. including (2S)-2-phenylpropane-1-
sulfonamide (PDB ID: VW4), N-(2-
phenylethyl)methanesulfonamide (PDB ID: JFM), 2-
(trifluoromethoxy)benzoic acid (PDB ID: K2P), (2S)-
2-(4-cyanophenoxy)propanamide (PDB ID: VW1), 1-
(propane-2-yl)-1H-imidazole-4-sulfonamide (PDB ID: 
NYV), 1-(2-ethoxyphenyl)piperazine (PDB ID: H04), 
3-(acetylamino)-4-fluorobenzoic acid (PDB ID: NZG), 
and (3S,4R)-1-acetyl-4-phenylpyrrolidine-3-
carboxylic acid (PDB ID: VXG). Accordingly, a total 
of 27 residues were noticed to be involved in the 
catalytic domain of the helicase including Arg-129, 
Leu-132, Phe-133, Asn-177, Ser-264, Gly-285, Thr-
286, His-290, Cys-309, His-311, Lys-320, Thy-359, 
Asn-361, Arg-442, His-482, Ser-485, Ser-486, Ala-
487, Ala-505, Trp-506, Tyr-515, Asn-516, Tyr-543, 
Thy-552, Ala-553, His-554, and Cys-556.  
For each component and the control inhibitors, 
a total of 50 docked configurations were produced. 
Among all conformations, the one with the most 
negative ∆G binding involved in the largest cluster was 
selected for further analyses, including interaction 
modes and MD simulation in a period of 500 
picoseconds (ps). The interactions between ligands and 
the helicase enzyme were visualized and analyzed 
using the BIOVIA Discovery Studio Visualizer 
version 19.1.0.18287. 
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Phenolics-residue interaction network: A total of 16 
phenolics were predicted as potentially able to connect 
with the SARS-CoV-2 catalytic site at either 
nanomolar or picomolar scale with a considerable 
binding affinity of below −10 kcal/mol. These 
compounds were considered top-ranked SARS-CoV-2 
helicase inhibitors.  
The post-docking analysis identified the 
interacting residues with these top-ranked phenolics. 
The hole hydrogen, hydrophobic, electrostatic, and 
miscellaneous interactions between top-ranked 
inhibitors and their connected residues were illustrated 
to achieve the PRI network. This was performed using 
the Cytoscape version 3.8.0. 
 
Results 
Molecular docking and molecular dynamics 
simulations: The binding affinity of several 
polyphenolics with the SARS-CoV-2 helicase catalytic 
site was evaluated using an in silico approach to 
combat Covid-19. A total of 16 components had a ∆G 
binding value of less than −10 kcal/mol, and therefore, 
these compounds were noticed to be top-ranked 
promising inhibitors of SARS-CoV-2 helicase.  
Three of them, amentoflavone, theaflavin 3'-
gallate, and procyanidin, showed the most considerable 
inhibition constant value (Ki), which were calculated 
to be at the picomolar (pM) scale.  
The next 13 inhibitors were estimated to block 
the catalytic site of the helicase at the nanomolar (nM) 
scale. Between the control compounds, vapreotide 
demonstrated the best ∆G binding and Ki with the values 
of −10.11 kcal/mol and 38.98 nM, respectively.  
Besides, among top-ranked ligands, vitexin 
presented the minimum binding affinity to the helicase 
catalytic site with the ∆G binding and Ki value of −10.19 
kcal/mol and 33.69 nM. Therefore, the present results 
show that all the top-ranked phenolics in this study can 
 
Figure 1. The estimated energy of binding for the top 16 phenolics and control components. X-axis: green diamonds 
indicate controls. The red ones demonstrate phenolics with the constant inhibition value at the picomolar scale, while the 
yellow spots represent the other potential inhibitors with the inhibition constant at the nanomolar scale. Y-axis represents 
the estimated energy of binding (kcal/mol). 
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potentially block the catalytic site of the SARA-CoV-
2 helicase more effectively than the control inhibitors 
in silico (Fig. 1). Table 1 demonstrates the ∆G binding 
and the Ki value for all the phenolics and the control 
inhibitors tested in the present study. The details of 
energies calculated from the binding of the top-ranked 
 
Figure 2. Interaction types after the post docking analysis between SARS-CoV-2 helicase catalytic site and (A) 
amentoflavone, (B) theaflavin 3'-gallate, (C) procyanidin, (D) rutin, (E) procyanidin B4, (F) nicotiflorin, (G) catechin 
gallate, (H) procyanidin D, (I) quercitrin, (J) gallocatechin gallate, (K) procyanidin B3, (L) procyanidin C2, (M) 
proanthocyanidin, (N) cyanidin 3-o-glucoside, (O) vicenin-2, and (P) vitexin. 
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components to the SARS-CoV-2 catalytic site, from 
which the ∆G binding is calculated, are presented in 
Table 2. Moreover, after the molecular docking studies 
analyzed the hydrogen, hydrophobic, electrostatic, and 
miscellaneous interactions among top-ranked small 
molecules, control compounds, and the residues within 
 
Figure 2. Continued. 
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the helicase catalytic site presented in Table 3. A. The 
related 2D images for the best 16 phenolics are 
demonstrated in Fig. 2. MD was simulated to examine 
the strength of interactions between amentoflavone, 
theaflavin 3'-gallate, procyanidin, and helicase 
residues. The interaction modes after the MD 
simulations are presented in Table 3. B and Fig. 3. 
 
PRI network analysis: A PRI network was 
constructed with the criteria of 55 nodes, including 16 
top-ranked potential inhibitors and 39 residues, and 
150 edges (Fig. 4). Each edge shows an interaction 
between a residue and a component. The number of 
edges linked to a component was calculated (known as 
degree) using the Cytoscape software (Fig. 5). It was 
found that Asp534 and Leu412 had the most 
interactions with phenolics. 
 
Discussion 
The NTPase/helicase is responsible for unwinding the 
nucleic acid of SARS-CoV-2, leading to genome 
replication of the virus (12, 39). Accordingly, NSP13 
was considered for anti-SARS-CoV-2 drug discovery 
 
Figure 3. Left figures show three-dimensional position after docking analysis, while the right images illustrate the two-
dimensional view of interactions after the MD simulations for (A) amentoflavone, (B) theaflavin 3'-gallate, and (C) 
procyanidin within the SARS-CoV-2 helicase catalytic site. MD, molecular dynamics. 
Bioinformatics Prediction of Potential Inhibitors For the SARS-CoV-2 NTPase/Helicase …                           Saidijam et al. 
Vol 6, No 3,  Summer 2021 
229 
in the current study. A total of 52 natural phenolic 
compounds were screened for the identification of 
potential helicase inhibitors. MD was  
 
 
Figure 4. PRI network illustrating interactions among top 16 phenolics and the residues of SARS-CoV-2 helicase 
catalytic site. PRI, phenolics-residues interaction. 
 
Figure 5. Degree diagram. The X-axis represents the residues within the SARS-CoV-2 helicase catalytic site interacting 
with the top 16 inhibitors. Y-axis demonstrates the number of interactions for each amino acid. 
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Table 1: Estimated free energy of binding and inhibition constant values were calculated for the tested natural 
compounds and the control inhibitors in this study using an in silico approach. 
PubChem ID Ligand name 
Estimated free energy of 
binding  (kcal/mol) 
Ki 
5281600 Amentoflavone -13.92 62.72 pM 
136825043 Theaflavin 3'-gallate   -12.90  348.75 pM 
107876 Procyanidin -12.77  436.10 pM 
5280805 Rutin  -11.38  4.57 nM 
147299 Procyanidin B4  -11.10 7.31 nM 
5318767 Nicotiflorin -10.93  9.69 nM  
6419835 Catechin gallate  -10.83  11.61 nM 
130556 Procyanidin D  -10.82  11.75 nM 
5280459 Quercitrin -10.76  13.04 nM 
199472 Gallocatechin gallate   -10.63  16.22 nM 
146798 Procyanidin B3  -10.43 22.64 nM  
11182062 Procyanidin C2  -10.40  23.61 nM 
108065 Proanthocyanidin  -10.34  26.55 nM 
441667 Cyanidin 3-o-glucoside  -10.26  30.09 nM  
442664 Vicenin-2 -10.20  33.59 nM  
5280441 Vitexin -10.19  33.69 nM  
122738 Procyanidin B2  -9.96  50.36 nM  
5280704 apigenin-7-glucoside -9.88  47.97 nM 
5280804 Isoquercitrin -9.87  58.01 nM 
124017 Procyanidol B5 -9.60  92.38 nM 
124052 glabridin  -9.37 134.67 nM 
5281675 orientin  -9.37 136.45 nM 
5353915 Quercetin-3-rhamnoside -9.21  176.55 nM  
474541 Procyanidin B8 -9.17    188.37 nM 
124025 Procyanidin A2 -8.93 282.96 nM  
5318997 Icariin -8.24    918.46 nM 
94672 Sesaminol  -8.13  1.10 uM 
5281654 Isorhamnetin -7.91  1.60 uM 
5280445 Luteolin -7.89      1.64 uM 
72277 Epigallocatechin   -7.89   1.64 uM 
638278 Isoliquiritigenin  -7.80   1.93 uM 
101612 Asarinin  -7.75 2.10 uM 
86289522 baicalein(1-) -7.69  2.29 uM  
5280443 apigenin  -7.69 2.32 uM 
1203 Epicatechin -7.59 2.72 uM 
5280343 Quercetin  -7.54  2.97 uM 
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5281607 Chrysin  -7.53    3.00 uM  
629440 Hemileiocarpin  -7.52 3.06 uM 
5280863 Kaempferol  -7.51  3.11 uM 
439533 taxifolin -7.49  3.26 uM  
65084 Gallocatechin  -7.42  3.61 uM 
5281672 Myricetin -7.36  963.30 nM 
5318998 licochalcone a      -7.32 4.27 uM  
9064 Catechin  -7.30 4.45 uM 
72307 sesamin  -7.28  4.58 uM 
14309735 Xanthogalenol -7.25  4.88 uM 
72344 Nobiletin -7.19  5.37 uM  
443639 Epiafzelechin   -7.02 7.14 uM  
12241084 Daidzein-3',5',8-d3   -6.74 11.49 uM  
145858 Flavylium    -6.73 11.62 uM  
5280378 Formononetin -6.59  14.85 uM 
5280544 Herbacetin  -6.54 16.01 uM 
6918026 Vapreotide (Ctrl) -10.11 38.98nM 
148192 Atazanavir (Ctrl) -9.74 72.68 nM 
6321424 Ivermectin (Ctrl) -8.96 268.85 nM 
5281697 Scutellarein (Ctrl) -8.16 1.05 uM 
Ki, inhibition constant. 
 
also simulated for top-ranked inhibitors. The results of 
the present study are important due to several reasons:  
 
 First, a total of 16 plant-based compounds 
were estimated to attach the SARS-CoV-2 
catalytic domain more tightly than the control 
inhibitors 
 Second, it was predicted that amentoflavone, 
theaflavin 3'-gallate, and procyanidin can 
block the SARS-CoV-2 catalytic domain at 
the picomolar concentration, which is not 
always achievable by molecular docking 
analysis. 
 
In addition, the docked pose of these compounds was 
found to be stable in the simulation on the 500 ps time 
scale. Moreover, herbal inhibitors have advantages 
compared to synthetic compounds due to availability, 
low price, and safety aspects, to name a few (40). 
Experimental approaches have previously 
demonstrated the anti-SARS-CoV NTPase/helicase 
activity of several flavonoids. Quercetin has been 
reported to be a potent inhibitor of SARS-CoV 
NTPase/helicase; the half-maximal inhibitory 
concentration (IC50) of quercetin against the unwinding 
activity of the enzyme was reported to be 8.1 μM. This 
was performed by applying the recombinant helicase 
and a fluorescence resonance energy transfer (FRET)-
based assay (41).  
Moreover, Park et al. (42) demonstrated the 
anti-SARS-CoV NTPase/helicase activity of several 
derivatives of 7-O-aryl-methyl quercetin; the IC50 of 
the compounds were reported from 2.7 to 5.2 μM.  
According to a study by Yu et al. (12), 
scutellarein and myricetin have displayed anti-ATPase 
activity against the SARS-CoV helicase with IC50 
values of 0.86 and 2.71 μM, respectively. In the present 
study, it was estimated that quercetin and quercetin-3-
rhamnoside could connect to the catalytic domain of 
SARS-CoV-2 NTPase/helicase with the ∆G binding of 
−7.54 and −9.21 kcal/mol, respectively, while the 
estimated energy of binding between myricetin and 
SARS-CoV-2 NTPase/helicase was −7.36 kcal/mol. 
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Black tea is a well-known beverage obtained from the 
leaves of the Camellia sinens containing a considerable 
number of orange-red pigments, which are the rich 
sources of theaflavins (TFs) such as theaflavin, 
theaflavin-3-gallate, and theaflavin-3,3′-digallate with 
many valuable health effects. Previous studies have 
reported antioxidant and pro-oxidant properties for 
TFs, leading to tumorigenesis prevention and selective 
cytotoxicity against cancer cells, respectively (43-49). 
Our results estimated that theaflavin 3'-gallate could 
bind to the SARS-CoV-2 helicase catalytic site at the 
picomolar scale (Ki = 348.75 pM) with a considerable 
∆G binding of −12.90 kcal/mol. Furthermore, before MD 
simulation, theaflavin 3'-gallate exhibited nine 
hydrogens and five hydrophobic interactions with 
Arg409, Leu412, Leu417, Pro514, Tyr515, Asn516, 
Asp534, Tyr552, Ala553, and His554 residues within 
the helicase catalytic site. In comparison, this 
compound illustrated thirteen hydrogens and four 
hydrophobic interactions with the Asn179, Ala407, 
Arg409, Leu412, Thr416, Leu417, Ser486, Tyr515, 
Asn516, Asp534, and His554 amino acids within the 
helicase catalytic site, after the MD simulation. Of 
note, a π-π stack pairing was found between His554 
and theaflavin 3'-gallate before and after MD 
simulations with the length of 6.00 Å and 4.83 Å, 
respectively. The π-π stack pairing is the main 
interaction mode between drugs and proteins, which 
creates a stable drug-protein connection (37). Clark et 
al. (50) reported that the combination of theaflavin, 
theaflavin-3-monogallate, theaflavin-3′-monogallate, 
and theaflavin-3,3′digallate revealed anti-bovine 
coronavirus (BCV) activity with the criteria of mean 
effective concentration (EC50) = 34.7 μg/ml. These 
authors used the HRT-18 cell line for their 
experiments. Lung et al. (51) designed a study to  




















Amentoflavone -11.88 -6.1 2.68 -1.38 -13.92 
Theaflavin 3'-gallate  -13.12 -6.71 4.77 -2.16  -12.90 
Procyanidin -12.14 -6.43 4.18 -1.62 -12.77 
Rutin -8.88 -9.38 4.77 -2.11  -11.38 
Procyanidin B4 -11.18 -5.64 3.88 -1.84  -11.10 
Nicotiflorin -8.87 -8.61 4.47 -2.08 -10.93 
Catechin gallate  -10.48 -4.9 3.28 -1.28 -10.83  
Procyanidin D -12.49 -3.93 3.88 -1.72  -10.82  
Quercitrin -11.57 -3.54 2.98 -1.38 -10.76 
Gallocatechin gallate  -10.86 -4.76 3.58 -1.42  -10.63  
Procyanidin B3 -11.52 -4.79 3.88 -2.01  -10.43 
Procyanidin C2 -11.51 -8.54 5.97 -3.68  -10.40 
Proanthocyanidin  -12.01 -3.92 3.88 -1.72 -10.34  
Cyanidin 3-o-glucoside -11.79 -3.45 3.58 -1.41  -10.26 
Vicenin-2 -9.88 -7.55 4.77 -2.46 -10.20 
Vitexin -9.47 -4.84 2.98 -1.13 -10.19  
Vapreotide (Ctrl) -9.87 -6.5 4.18 -2.09 -10.11 
Atazanavir (Ctrl) -10.09 -4.93 3.58 -1.71 -9.74 
Ivermectin (Ctrl) -9.17 -1.19 0.89 -0.5 -8.96 
Scutellarein (Ctrl) -8.16 0 0 0 -8.16 
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Table 3: Different types of interactions between the top inhibitors in this study and SARS-CoV-2 catalytic site residues. 
 
A, Before molecular dynamics simulations 








Asn177 (5.01: classical); Asp534 
(4.19: classical); Gly415 (3.55*: 
classical); Leu417 (2.61: classical) 
His554 (5.91*: pi); Leu412 (4.33*: 
mixed, 4.77*: mixed) 
NA NA 
Theaflavin 3'-gallate 
Tyr515 (5.18*: classical); Asn516 
(4.14*: classical); Pro514 (5.00: 
classical); Asp534 (3.24*: classical); 
Arg409 (3.71*: classical, 4.98: 
classical); Leu417 (3.03*: classical, 
3.43: classical); Tyr552 (3.47: 
classical);  
His554 (6.00*: pi, 6.43*: mixed); 
Leu412 (5.06*: mixed); Ala553 
(5.38: mixed, 5.44*: alkyl);  
NA NA 
Procyanidin 
Thr416 (3.84: non-classical); Leu417 
(2.70: classical); Asn557 (4.20*: 
classical); Arg560 (4.78*: classical, 
6.02*: classical); Asn177 (4.03: 
classical, 5.13: classical); Asp534 
(4.37*: classical); Pro406 (4.26*: non-
classical) 
Leu412 (6.33: mixed); Pro408 




Tyr180 (5.24); Asn177 (4.79); Thr410 
(3.62); Arg409 (4.99); Leu417 
(2.95,3.06) 
Leu417 (6.20); Leu412 (4.09,4.88) NA NA 
Procyanidin B4 
Ala407 (4.15,4.41); Thr416 (3.66); 
Leu417 (3.34); Arg560 (5.60); Thr413 
(3.47); Leu412 (3.05) 
His554 (4.95); Leu417 (6.12); 




Asn179 (3.93); Thr228(3.29); Glu143 
(4.12,4.41); Glu142 (3.46,4.31)  
Val181 (4.22) NA NA 
Catechin gallate  
Asp534 (4.24); Met378 (4.55); Pro406 
(3.33,3.60); Pro408 (4.54); Arg409 
(3.70); Arg560 (6.88); Leu417 (4.62); 
Gly415 (3.43,3.82) 
Ala407 (5.34); Pro408 (4.06,4.11); 
Leu405 (4.61,5.67); Leu412 (5.56); 
Pro406 (4.58) 
Asp534 (4.86) Met378 (6.81) 
Procyanidin D 
Gly415 (4.17); Leu417 (3.63); Arg409 
(3.76); Thr410(3.44); Asn179(4.64); 
Asp534 (3.36); Met378 (3.89); Pro406 
(4.09) 
Leu412 (4.49); His554 (4.92); 






Met378 (4.06); Pro406 (3.88,4.69); 
Leu417 (3.34); Thr416 (3.38); Asn557 
(3.90); Leu412 (3.24,4.30); Arg409 
(5.21); Asn179 (4.55,5.47); Pro408 
(4.18) 
Pro406 (3.88,4.94,5.84); Ala407 
(5.37,6.13); Pro408 
(3.82,4.31,4.66); Leu405 (5.79) 
Asp534 (4.88,6.42) Met378 (4.74) 
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Gallocatechin gallate  
Gly415 (3.48,4.14); Arg560 (6.43); 
Arg409 (3.93,4.98,5.32); Pro408 
(4.70); Pro406 (3.99); Met378 (4.12); 
Asp534 (4.55); Leu412 (4.52) 
Pro408 (4.06,4.11); Pro406(4.58); 
Leu405 (4.61,5.67); Ala407 (5.36); 
Leu412 (5.56) 
Asp534(4.57) Met378 (4.99) 
Procyanidin B3 
Tyr515 (3.70); Asn516 (4.08); Ser486 
(4.18); Asn177 (4.15,4.17); Thr410 
(3.73); Asp534 (4.87); Arg560 (6.72); 
Asn557 (4.48); Leu412 (4.39,4.45) 
His554 (4.61,6.59); Pro406 (6.70) NA NA 
Procyanidin C2 
Gly527 (4.25); Leu528 (6.53); Thr530 
(3.23,5.14); Gln531 (4.36); Ser539 
(4.46) 
Pro529 (4.82,4.93,5.04); Val510 
(7.03) 
Asp542 (6.16) NA 
Proanthocyanidin  
His554 (5.40); Thr410 (3.18); Arg409 
(4.60); Pro406 (4.15); Met378 (3.86); 
Asn557 (5.34); Gly415 (3.79) 
Leu412 (4.36); His554 (5.12); 
Leu405 (5.84); Ala407 (6.05); 
Pro408 (4.06); Pro406 (5.41) 
Asp534 (5.60) Met378 (4.62,8.43) 
Cyanidin 3-o-
glucoside 
Leu412 (3.34,4.28); Arg409 (6.98); 
Thr410 (3.68,3.89); Asn179 (4.50); 
Tyr180 (5.19); Met378 (4.51); Pro406 
(3.75); Leu417 (3.01,4.15) 
Leu405 (5.71); Pro408 (3.69,4.47); 
Ala407 (5.13,5.98); Pro406 
(3.75,4.60,5.80); Leu412 (6.59); 
Leu417 (6.40) 
Asp534 (4.77) Met378 (5.20) 
Vicenin-2 
Leu417 (4.27,4.31); Gly415 
(3.72,3.86); Arg560 (5.80); Asp534 
(4.78); Tyr515 (5.30); His554 (3.55) 





Thr410 (3.14,4.18); Thr413 (3.66); 
Leu412 (4.07,4.74); Arg409 (6.32); 
Asn177 (3.80); Ala407 (4.44); Pro406 
(4.04); Arg560 (6.38) 
Pro408 (4.48,5.29); Arg409 (6.32); 
Arg178 (6.98) 
Asp534 (5.06) NA 
Atazanavir (Ctrl) 
Phe343 (5.87); Cys342 (4.25); Lys345 
(5.55); Ala312 (2.97); Asp315 (4.36); 
Ser539 (4.03) 
Ala312 (4.27,4.94); Ala313 (5.58); 





Gln531 (3.59); Cys342 (4.43); Asp315 






Tyr541 (4.30); Asp542 (3.30); Lys569 
(5.48); Glu319 (4.28); Lys345 
(5.19,5.87) 
Tyr541 (6.28); Val510 (5.03); 
Pro529 (6.16) 
NA NA 
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Scutellarein (Ctrl) 
Asp534 (5.39); Asn179 (5.29); Thr416 
(3.37); Leu417 (3.72) 
Pro46 (3.89,4.97,5.80); Leu417 
(6.32); Leu405 (5.82); Pro408 
(3.80,4.74); Ala407 (5.43,6.10); 
Leu412 (6.42) 
Asp534 (4.98) Met378 (4.90) 
B, After molecular dynamics simulations 
Ligand name Hydrogen bond (distance Å) 







Leu412 (4.74: classical); Gly415 (3.31: 
classical, 4.37: classical); Thy416 
(3.91: classical); Arg409 (4.75: 
classical;); Pro408 (4.43: non-classic) 
Thr410 (5.00: pi); His554 (5.28: pi, 
5.56: pi); Pro175 (6.49: mixed); 
Leu412 (5.16: mixed, 5.55: mixed) 
NA NA 
Theaflavin 3'-gallate 
Tyr515 (5.21: classical); His554 (4.50: 
classical); Arg409 (5.84: classical); 
Ala407 (5.26: classical); Leu417 (4.88: 
classical); Asn516 (3.18: classical, 
3.39: classical); Ser486 (3.29: 
classical, 4.27: classical); Asp534 
(3.85:’ classical); Asn179 (3.88: 
classical); Leu412 (4.70: non-
classical); Thr416 (3.83: non-classical) 
His554 (4.83: pi, 5.62: mixed, 5.80: 
mixed); Arg409 (7.71: mixed); 




Asp534 (3.07: classical); Ala407 (4.15: 
classical); Arg409 (4.30: classical); 
Pro406 (3.73: non-classical); Asn557 
(4.29: classical); Arg560 (4.39: 
classical, 6.05: classical) 
Pro175 (5.88: mixed); Tyr180 (6.37: 
mixed); Arg409 (7.52: mixed) 
NA NA 
The asterisks (*) show the interactions that were found to be stable after MD simulations. MD, molecular dynamics; NA, 
not available. 
 
evaluate the binding affinity of several traditional 
Chinese medicinal compounds with the catalytic site of 
RNA‐dependent RNA polymerase (RdRp) in SARS‐
CoV SARS‐CoV-2, and Middle East respiratory 
syndrome coronavirus (MERS‐CoV) using the idock 
protein-ligand docking tool 
(https://GitHub.com/HongjianLi/idock). The authors 
reported that theaflavin revealed binding energy of 
−9.11 kcal/mol, −8.03 kcal/mol, and −8.26 kcal/mol 
with the RdRp of SARS‐CoV‐2, SARS‐CoV, and 
MERS‐CoV, respectively. 
Amentoflavone is a biflavone metabolite with 
several health benefits, including antioxidative, anti-
inflammatory, anticancer, antimicrobial, 
neuroprotective, and anti-radiational characteristics 
(52-63). According to the present results, it was 
estimated that amentoflavone could attach to the 
catalytic site of SARS-CoV-2 helicase at the picomolar 
scale (Ki = 62.72 pM) with an outstanding ∆G binding of 
−13.92 kcal/mol. Before MD simulation, 
amentoflavone formed four hydrogens, three 
hydrophobic and one unfavorable interaction with 
Asn177, Tyr180, Leu412, Gly415, Leu417, Asp534, 
and His554 residues inside the helicase catalytic site. 
In comparison, this ligand showed six hydrogens and 
six hydrophobic interactions with Pro175, Pro408, 
Arg409, Thy410, Leu412, Gly415, Tyr416, and 
His554 residues inside the helicase catalytic site after 
the MD simulation. A π-π stack pairing was detected 
between amentoflavone and His554 (5.91 Å) before 
MD simulation, while after the MD simulation, 
amentoflavone demonstrated one and two π-π stack 
pairing interactions with the Thr410 (5.00 Å) and 
His554 (5.28 Å, 5.56 Å), respectively. Ryu et al. (64) 
conducted a study to examine the anti-SARS-CoV 
3CLPro activity of Torreya nucifera leaves extracts, 
which is widely used in traditional medicine in Asia. 
The authors reported that amentoflavone had the 
strongest inhibitory effect among the extract 
components on the 3CLPro activity with an IC50 and Ki 
value of 8.3 µM and 13.8 µM, respectively: this was 
carried out using the fluorescence resonance energy 
Saidijam et al.                            Bioinformatics Prediction of Potential Inhibitors For the SARS-CoV-2 NTPase/Helicase … 
Journal of Cellular & Molecular Anesthesia (JCMA) 
236 
transfer (FRET) and molecular docking analysis. 
Several plants have been identified as the rich sources 
of amentoflavone, such as Ginkgo biloba, Selaginella 
tamariscina, Juniperus communis L, Hypericum 
perforatum, and Biophytum sensitivum (65-68). 
Procyanidins are the most abundant subgroup of 
flavonoids with many pharmaceutical properties 
including antioxidant, anti‐inflammatory, antitumor, 
and cardioprotective effects. Structurally, they consist 
of two monomers of catechins and epicatechins 
forming dimers, trimers, tetramers, or more massive 
molecules. These metabolites are mainly found in 
grape juice, grape seed, apple, and cocoa (69-74). 
Zhuang et al. (75) studied the antiviral activity of 
butanol fraction obtained from the Cinnamomi Cortex 
on the wild-type of SARS-CoV (wtSARS-CoV). The 
authors demonstrated that procyanidin A2 and 
procyanidin B1 had a mild effect on the activity of 
wtSARS-CoV with an IC50 value between 30 and 40 
μM. This was carried out using the plaque reduction 
assay. Based on our findings, it was predicted that 
procyanidin could considerably connect to the SARS-
CoV-2 helicase catalytic site at the picomolar scale (Ki 
= 436.10 pM) with a ∆G binding of −12.77 kcal/mol. 
Moreover, before MD simulation, procyanidin 
exhibited nine hydrogens and four hydrophobic 
interactions with Asn177, Pro406, Pro408, Leu412, 
Tyr416, Leu417, Asp534, Asn557, and Arg560 
residues within the helicase catalytic site. In 
comparison, this component demonstrated seven 
hydrogens and three hydrophobic interactions with the 
Pro175, Tyr180, Pro406, Ala407, Arg409, Asp534, 
Asn557, and Arg560 residues inside the helicase 
catalytic site after the MD simulation. It was also 
predicted that procyanidin B4, procyanidin D, 
procyanidin B3, procyanidin C2, proanthocyanidin, 
procyanidin B2, procyanidin B5, procyanidin B8, and 
procyanidin A2 could attach to the SARS-CoV-2 
helicase catalytic site at the nanomolar scale with the 
∆G binding ranging from −11.10 (for procyanidin B4) to 
−8.93 kcal/mol (for procyanidin A2). 
Based on MD simulations, it was found that 
amentoflavone illustrated four stable interactions with 
the SARS-CoV-2 helicase catalytic domain, including 
one hydrogen and three hydrophobic interactions. 
Also, theaflavin 3'-gallate formed nine stable 
interactions with the residues within the enzyme 
including five hydrogens and four hydrophobic 
interactions. Moreover, procyanidin demonstrated five 
hydrogen bonds with the amino acids inside the SARS-
CoV-2 helicase. Therefore, the docked pose of 
amentoflavone, theaflavin 3'-gallate, and procyanidin 
was revealed to be stable, suggesting that these 
compounds could be considered as potentially 
effective inhibitors of the SARS-CoV-2 
NTPase/helicase and may disrupt the unwinding 
process of the viral RNA. The three-dimensional 
docked pose of amentoflavone, theaflavin 3'-gallate, 
and procyanidin after MD simulations are illustrated in 
Fig. 3. 
There are some limitations in the present study. 
No supercomputer was available for the research team 
to perform MD simulations. Besides, the helicase 
enzyme within the 5RLJ file contained 592 residues. 
Therefore, the MD simulation was time-consuming for 
the research team and took several days to complete the 
MD simulation for each ligand-protein complex. 
Performing MD simulation for greater time scales is 
suggested in future studies, although it needs faster 
processors in silico. It is also suggested that MD 
simulation be applied for other top-ranked compounds 
in this study to reveal more potentially effective 
inhibitors of SARS-CoV-2 helicase. Furthermore, wet-
lab experiments are required to confirm our findings. 
 
Conclusion 
In summary, the present study suggests that 
amentoflavone, theaflavin 3'-gallate, and procyanidin 
could be considered potentially effective inhibitors of 
the enzyme, leading to disruption in the viral RNA 
replication. This was carried out using molecular 
docking and dynamics simulations. Besides, Asp534 
and Leu412 were the most active amino acids within 
the catalytic domain of the enzyme. However, in vitro 
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